Characterization of chondroblastic osteosarcoma: gadolinium-enhanced versus diffusion-weighted MR Imaging

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 4, 2009, Pages 895-900

  Yakushiji, Toshitake ^a   Oka, Kiyoshi ^a   Sato, Hiro ^a   Yorimitsu, Shigeta ^a   Fujimoto, Toru ^a   Yamashita, Yasuyuki ^a   Mizuta, Hiroshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Apparent diffusion coefficient (adc); Chondroblastic osteosarcoma; Chondrosarcoma; Diffusion weighted imaging (dwi)

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CHILD; CHONDROBLASTIC OSTEOSARCOMA; CHONDROSARCOMA; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CHILD; CHONDROSARCOMA; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; ECHO-PLANAR IMAGING; FEMALE; GADOLINIUM; HUMANS; MALE; MIDDLE AGED; OSTEOSARCOMA;

EID: 65249154158     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21703     Document Type: Article

References (23)

1. Dorfman HD, Czerniak B. Bone tumors. St Louis: Mosby, 1997; 128-219.
2. MirraJM. Bone tumours. Philadelphia: Lea&Febiger; 1989:248-350.
3. Dorfman HD, Czerniak B. Bone cancers. Cancer 1995;75:203-210.
4. Bacci G, Bertoni F, Longhi A, et al. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histological response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 2003;97:3068-3075.
5. Price CHG. Osteogenic sarcoma. An analysis of survival and its relationship to histological grading and structure. J Bone Joint Surg 1961;43-B:300-313.
6. Hauben EI, Weeden S, Pringle J, van Marck EA, Hogendoorn PCW. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer 2002;38:1218-1225.
7. Geirnaerdt MJA, Bloem JL, Eulderink F, Hogendoorn PCW, Tamin- iau AHM. Cartilaginous tumors: correlation of gadolinium-enhanced mr imaging and histopathologic findings. Radiology 1993; 186:813-817.
8. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002;16:172-178.
9. Murakami R, Sugahara T, Nakamura H, et al. Malignant supraten- torial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 2007;243:493-499.
10. Okamoto K, Ito J, Ishikawa K, Sakai K, Tokiguchi S. Diffusion- weighted echo-planar MR imaging in differential diagnosis of brain tumors and tumor-like conditions. Eur Radiol 2000;10:1342-1350.
11. Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion- weighted MRI with echo-planar technique in the evaluation of cel- lularity in gliomas. J Magn Reson Imaging 1999;9:53-60.
12. Baur A, Reiser MF. Diffusion-weighted imaging ofthe musculoskel et al system in humans. Skelet al Radiol 2000;29:555-562.
13. Einarsdottir H, Karlsson M, Wejde J, Bauer HC. Diffusion-weighted MRI of soft tissue tumors. Eur Radiol 2004;14:959-963.
14. Hayashida Y, Hirai T, Yakushiji T, et al. Evaluation of diffusion- weighted imaging for the differential diagnosis of poorly contrast- enhanced and T2-prolonged bone masses: initial experience. J Magn Reson Imaging 2006;23:377-382.
15. Lang P, Wendland MF, Saeed M, et al. Osteogenic sarcoma: non- invasive in vivo assessment of tumor necrosis with diffusionweighted MR imaging. Radiology 1998;206:227-235.
16. van Rijswijk CS, Kunz P, Hogendoorn PC, Taminiau AH, Doornbos J, Bloem JL. Diffusion-weighted MRI in the characterization of soft-tissue tumors. J Magn Reson Imaging 2002;15:302-307.
17. Geirnaerdt MJA, Bloem JL, van der Woude HK, Taminiau AHM, Nooy MA, Hogendoorn PCW. Chondroblastic osteosarcoma: characterization by gadolinium-enhanced MR imaging correlated with histopathology. Skelet al Radiol 1998;27:145-153.
18. Hayashida Y, Yakushiji T, Awai K, et al. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted imaging: initial results. Eur Radiol 2006;16:2637-2643.
19. Oka K, Yakushiji T, Sato H, et al. The ability of diffusion-weighted imaging for the differential diagnosis between choronic expanding hematomas and malignant soft tissue tumors. J Magn Reson Imaging 2008;28:1195-1200.
20. Erlemann R, Reiser MF, Peters PE, et al. Musculoskelet al neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 1989;171:767-773.
21. De Beuckeleer LHL, De Schepper AMA, Ramon F. Magnetic resonance imaging of cartilaginous tumors: is it useful or necessary? Skelet al Radiol 1996;25:137-141.
22. De Beuckeleer LHL, De Schepper AMA, Ramon F, Somville J. Magnetic resonance imaging of cartilaginous tumors: a retrospective study of 79 patients. Eur J Radiol 1999;21:34-40.
23. Gonzalez RG, Schaefer PW, Buonanno FS, Schwamm LH, Weiss- koff RM, Koroshetz WJ. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 1999;210:155-162.